Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 472

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67

Open access
Tuominen, Vilppu J, Ruotoistenmäki, Sanna, Viitanen, Arttu, Jumppanen, Mervi, Isola, Jorma·2010·Breast Cancer Research

Abstract

Introduction: Accurate assessment of estrogen receptor (ER), progesterone receptor (PR), and Ki-67 is essential in the histopathologic diagnostics of breast cancer. Commercially available image analysis systems are usually bundled with dedicated analysis hardware and, to our knowledge, no easily installable, free software for immunostained slide scoring has been described. In this study, we describe a free, Internet-based web application for quantitative image analysis of ER, PR, and Ki-67 immunohistochemistry in breast cancer tissue sections. Methods: The application, named ImmunoRatio, calculates the percentage of positively stained nuclear area (labeling index) by using a color deconvolution algorithm for separating the staining components (diaminobenzidine and hematoxylin) and adaptive thresholding for nuclear area segmentation. ImmunoRatio was calibrated using cell counts defined visually as the gold standard (training set, n = 50). Validation was done using a separate set of 50 ER, PR, and Ki-67 stained slides (test set, n = 50). In addition, Ki-67 labeling indexes determined by ImmunoRatio were studied for their prognostic value in a retrospective cohort of 123 breast cancer patients. Results: The labeling indexes by calibrated ImmunoRatio analyses correlated well with those defined visually in the test set (correlation coefficient r = 0.98). Using the median Ki-67 labeling index (20%) as a cutoff, a hazard ratio of 2.2 was obtained in the survival analysis (n = 123, P = 0.01). ImmunoRatio was shown to adapt to various staining protocols, microscope setups, digital camera models, and image acquisition settings. The application can be used directly with web browsers running on modern operating systems (e.g., Microsoft Windows, Linux distributions, and Mac OS). No software downloads or installations are required. ImmunoRatio is open source software, and the web application is publicly accessible on our website. Conclusions: We anticipate that free web applications, such as ImmunoRatio, will make the quantitative image analysis of ER, PR, and Ki-67 easy and straightforward in the diagnostic assessment of breast cancer specimens.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/bcr2615

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 23

  1. Allred DC, Carlson RW, Berry DA, Burstein HJ, Edge SB, Goldstein LJ, Gown A, Hammond ME, Iglehart JD, Moench S, Pierce LJ, Ravdin P, Schnitt SJ, Wolff AC: NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry. J Natl Compr Canc Netw. 2009, 7: S1-S21. quiz S22-23 · DOI
  2. de Azambuja E, Cardoso F, de Castro G, Colozza M, Mano MS, Durbecq V, Sotiriou C, Larsimont D, Piccart-Gebhart MJ, Paesmans M: Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer. 2007, 96: 1504-1513. 10.1038/sj.bjc.6603756. · DOI · Paper page
  3. Stuart-Harris R, Caldas C, Pinder SE, Pharoah P: Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients. Breast. 2008, 17: 323-334. 10.1016/j.breast.2008.02.002. · DOI · Paper page
  4. Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thürlimann B, Senn HJ, Panel members: Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol. 2009, 20: 1319-1329. 10.1093/annonc/mdp322. · DOI · Paper page
  5. Harvey JM, Clark GM, Osborne CK, Allred DC: Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999, 17: 1474-1481. · DOI · Paper page
  6. Shousha S: Oestrogen receptor status of breast carcinoma: Allred/H score conversion table. Histopathology. 2008, 53: 346-347. 10.1111/j.1365-2559.2008.03075.x. · DOI
  7. Rüdiger T, Höfler H, Kreipe HH, Nizze H, Pfeifer U, Stein H, Dallenbach FE, Fischer HP, Mengel M, von Wasielewski R, Müller-Hermelink HK: Quality assurance in immunohistochemistry: results of an interlaboratory trial involving 172 pathologists. Am J Surg Pathol. 2002, 26: 873-882. 10.1097/00000478-200207000-00005. · doi:10.1097/00000478-200207000-00005
  8. Walker RA: Quantification of immunohistochemistry - issues concerning methods, utility and semiquantitative assessment I. Histopathology. 2006, 49: 406-410. 10.1111/j.1365-2559.2006.02514.x. · DOI · Paper page
  9. Taylor C, Levenson R: Quantification of immunohistochemistry - issues concerning methods, utility and semiquantitative assessment II. Histopathology. 2006, 49: 411-424. 10.1111/j.1365-2559.2006.02513.x. · DOI · Paper page
  10. Ruifrok AC, Johnston DA: Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol. 2001, 23: 291-299.
  11. Rojo MG, Bueno G, Slodkowska J: Review of imaging solutions for integrated quantitative immunohistochemistry in the Pathology daily practice. Folia Histochem Cytobiol. 2009, 47: 349-354. 10.2478/v10042-008-0114-4. · doi:10.2478/v10042-008-0114-4
  12. Sternberg SR: Biomedical Image Processing. IEEE Computer. 1983, 16: 22-34. · DOI · Paper page
  13. Ridler TW, Calvard S: Picture thresholding using an iterative selection method. IEEE Trans Systems Man and Cybernetics. 1978, 8: 630-632. 10.1109/TSMC.1978.4310039. · DOI · Paper page
  14. Beucher S, Meyer F: The morphological approach to segmentation: The watershed transformation. Mathematical Morphology in Image Processing. Edited by: Dougherty ER. 1993, New York: Marcel Dekker, 433-481. 1
  15. Mofidi R, Walsh R, Ridgway PF: Objective measurement of breast cancer oestrogen receptor status through digital image analysis. Eur J Surg Oncol. 2003, 29: 20-24. 10.1053/ejso.2002.1373. · DOI
  16. Faratian D, Kay C, Robson T, Campbell FM, Grant M, Rea D, Bartlett JM: Automated image analysis for high-throughput quantitative detection of ER and PR expression levels in large-scale clinical studies: the TEAM Trial Experience. Histopathology. 2009, 55: 587-593. 10.1111/j.1365-2559.2009.03419.x. · doi:10.1111/j.1365-2559.2009.03419.x
  17. Kostopoulos S, Cavouras D, Daskalakis A, Bougioukos P, Georgiadis P, Kagadis GC, Kalatzis I, Ravazoula P, Nikiforidis G: Colour-texture based image analysis method for assessing the hormone receptors status in breast tissue sections. Conf Proc IEEE Eng Med Biol Soc. 2007, 2007: 4985-4988.
  18. Pham NA, Morrison A, Schwock J, Aviel-Ronen S, Iakovlev V, Tsao MS, Ho J, Hedley DW: Quantitative image analysis of immunohistochemical stains using a CMYK color model. Diagn Pathol. 2007, 2: 8-10.1186/1746-1596-2-8. · DOI · Paper page
  19. Ruifrok AC, Katz RL, Johnston DA: Comparison of quantification of histochemical staining by hue-saturation-intensity (HSI) transformation and color-deconvolution. Appl Immunohistochem Mol Morphol. 2003, 11: 85-91. 10.1097/00022744-200303000-00014. · doi:10.1097/00022744-200303000-00014
  20. Rexhepaj E, Brennan DJ, Holloway P, Kay EW, McCann AH, Landberg G, Duffy MJ, Jirstrom K, Gallagher WM: Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer. Breast Cancer Res. 2008, 10: R89-10.1186/bcr2187. · DOI
  21. Kostopoulos S, Cavouras D, Daskalakis A, Kagadis GC, Kalatzis I, Georgiadis P, Ravazoula P, Nikiforidis G: Cascade pattern recognition structure for improving quantitative assessment of estrogen receptor status in breast tissue carcinomas. Anal Quant Cytol Histol. 2008, 30: 218-225.
  22. Gustavson MD, Bourke-Martin B, Reilly DM, Cregger M, Williams C, Tedeschi G, Pinard R, Christiansen J: Development of an unsupervised pixel-based clustering algorithm for compartmentalization of immunohistochemical expression using Automated QUantitative Analysis. Appl Immunohistochem Mol Morphol. 2009, 17: 329-337. 10.1097/PAI.0b013e318195ecaa. · doi:10.1097/pai.0b013e318195ecaa
  23. Camp RL, Chung GG, Rimm DL: Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med. 2002, 8: 1323-1327. 10.1038/nm791. · DOI · Paper page

Cited by

See all 472

Metadata

Authors
Tuominen, V. J., Ruotoistenmäki, S., Viitanen, A., Jumppanen, M., & Isola, J.
Venue
Breast Cancer Research
Published
2010-07-27
Volume
12
Issue
4
Pages
R56-R56
ISSN
  • 1465-5411 (ISSN-L)
  • 1465-542X
OpenAlex
W2133554539
Cited by
472
References
1
FWCI
16.66
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. https://app.cochat.ai/papers/10.1186/bcr2615
The paper
Tuominen, V. J., Ruotoistenmäki, S., Viitanen, A., Jumppanen, M., & Isola, J. (2010). ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Research. https://doi.org/10.1186/bcr2615

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.